IBDEI119 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,2006,0)
 ;;=INJECTIONS^11^141
 ;;^UTILITY(U,$J,358.4,2007,0)
 ;;=INJECTION ADMINISTRATION^10^141
 ;;^UTILITY(U,$J,358.4,2008,0)
 ;;=EAR WAX REMOVAL^5^141
 ;;^UTILITY(U,$J,358.4,2009,0)
 ;;=CARDIAC^2^141
 ;;^UTILITY(U,$J,358.4,2010,0)
 ;;=FOREIGN BODY^8^141
 ;;^UTILITY(U,$J,358.4,2011,0)
 ;;=UA/FINGERSTICK^15^141
 ;;^UTILITY(U,$J,358.4,2012,0)
 ;;=FLUSHES^6^141
 ;;^UTILITY(U,$J,358.4,2013,0)
 ;;=TB TEST^14^141
 ;;^UTILITY(U,$J,358.4,2014,0)
 ;;=DRAIN/INJECT JOINT^4^141
 ;;^UTILITY(U,$J,358.4,2015,0)
 ;;=DESTRUCTION OF LESIONS^3^141
 ;;^UTILITY(U,$J,358.4,2016,0)
 ;;=IMMUNIZATIONS^9^141
 ;;^UTILITY(U,$J,358.4,2017,0)
 ;;=IMMUNIZATION ADMINISTRATION^8^141
 ;;^UTILITY(U,$J,358.4,2018,0)
 ;;=PREVENTIVE MED-EST PT^12^141
 ;;^UTILITY(U,$J,358.4,2019,0)
 ;;=PREVENTIVE MED-NEW PT^13^141
 ;;^UTILITY(U,$J,358.4,2020,0)
 ;;=GENITOURINARY & RENAL^5^142
 ;;^UTILITY(U,$J,358.4,2021,0)
 ;;=GYNECOLOGICAL/BREAST^6^142
 ;;^UTILITY(U,$J,358.4,2022,0)
 ;;=CARDIO/VASCULAR^1^142
 ;;^UTILITY(U,$J,358.4,2023,0)
 ;;=ENDOCRINE/METABOLIC/NUTRITION^2^142
 ;;^UTILITY(U,$J,358.4,2024,0)
 ;;=EYES/EARS/NOSE^3^142
 ;;^UTILITY(U,$J,358.4,2025,0)
 ;;=GASTROINTESTINAL^4^142
 ;;^UTILITY(U,$J,358.4,2026,0)
 ;;=MUSCULOSKELETAL^9^142
 ;;^UTILITY(U,$J,358.4,2027,0)
 ;;=NEUROLOGY^10^142
 ;;^UTILITY(U,$J,358.4,2028,0)
 ;;=PULMONARY^11^142
 ;;^UTILITY(U,$J,358.4,2029,0)
 ;;=PSYCHIATRIC^12^142
 ;;^UTILITY(U,$J,358.4,2030,0)
 ;;=SKIN^13^142
 ;;^UTILITY(U,$J,358.4,2031,0)
 ;;=IMMUNIZATIONS^7^142
 ;;^UTILITY(U,$J,358.4,2032,0)
 ;;=MISCELLANEOUS^8^142
